ANDA 40837, held by Watson Labs Inc. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 40837 (Lidocaine Hydrochloride), held by Watson Labs Inc, was first approved by FDA on Mar 23, 2011, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 23, 2011 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride2% ยท jelly;topical | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters